Revolutionary vibration device offers pain relief for finger pricks, GLP-1 shots, and wellness injections
BOCA RATON, Fla., April 22, 2025 /PRNewswire/ — Suthe is proud to announce the launch of its new website, SutheDermal.com, introducing DigiVibe™—a groundbreaking device designed to alleviate the discomfort and anxiety associated with self-injections and finger pricking.
With the rising prevalence of injectable treatments for conditions like diabetes, fertility protocols & weight management, SutheDermal.com addresses a critical need for a more comfortable patient experience. DigiVibe™ employs advanced vibration technology to minimize pain perception, making self-injection more manageable for users.
The newly launched website offers:
“Our mission is to enhance the quality of life for individuals requiring regular injections by providing innovative solutions that reduce discomfort and anxiety,” said Mark Lorberbaum, Founder & CEO at Suthe.
For more information, visit https://suthedermal.com.
Media Contact:
Terri Previte, Director of Digital Marketing
Mark Lorberbaum, Founder & CEO
***@suthedermal.com
(844) 503-8423
Photos:
https://www.prlog.org/13072799
Press release distributed by PRLog
SOURCE Digivibe by Suthe
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…